Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain
Nervonix, a medical R&D company headquartered in Bozeman, MT, is cultivating technology that generates noninvasive 2D images of peripheral nerves. The images might ultimately be used to identify the location of nerves, providing the basis for pain diagnosis and management by anesthesiologists, surgeons, and other clinicians, according to the company. A portable device is being designed to deliver real-time, high-resolution nerve images from a patient's bedside or the operating table. Nervonix is collaborating with Battelle Memorial Institute to develop the technology into a viable product, which could be commercially available as early as mid-2004, according to Nervonix. The company is now looking for commercial partners, OEMs, and distributors to assist in its development and marketing efforts.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.